The Influence of the Coronavirus Disease 2019 Pandemic on Influenza Vaccination Refusal and Patient Satisfaction.

Publication date: Jul 01, 2025

We examined how the COVID-19 pandemic influenced influenza vaccination, healthcare engagement, and patient satisfaction. We retrospectively analyzed influenza vaccination records and patient experience surveys of adult primary care patients in southeastern Minnesota during two 3-year phases: Prepandemic (1 January 2017-28 February 2020) and Pandemic-Plus (1 March 2020-31 December 2023). Vaccination status was defined as “always vaccinated” (AV), “never vaccinated” (NV), or “intermittently vaccinated” (IV) for seasonal influenza. During the Pandemic-Plus phase, 7. 0% (n = 3556) of the Prepandemic AV and 48. 7% (n = 16 710) of the Prepandemic IV patients never received another influenza vaccine. Compared to AV, IV and NV patients were more likely to reside in areas with greater socioeconomic deprivation (odds ratio [OR], 1. 58 [95% confidence interval {CI}, 1. 53-1. 62] and 1. 99 [1. 94-2. 05], respectively), have a high school education or less (2. 86 [2. 74-2. 98] and 3. 38 [3. 23-3. 53]), and report healthcare disengagement (1. 59 [1. 55-1. 64] and 4. 21 [4. 09-4. 33]). After adjusting for Area Deprivation Index and medical comorbidities, healthcare disengagement increased among the NV versus AV between phases (3. 33 [3. 24-3. 41] and 4. 23 [4. 10-4. 35]). In a subgroup analysis those with severe comorbidities were less likely AV (NV vs AV: 1. 21 [1. 14-1. 27]) and more dissatisfied with care (NV vs AV: 1. 25 [1. 18-1. 33]). The COVID-19 pandemic altered vaccination behaviors and healthcare satisfaction, especially among those at high risk of developing influenza-related complications. Medical providers and public health officials should be aware of factors associated with vaccine refusal to better target interventions.

Open Access PDF

Concepts Keywords
Coronavirus COVID-19
Education Engagement
Vaccinated Vaccination

Semantics

Type Source Name
disease MESH Coronavirus Disease 2019
disease MESH Influenza
disease MESH complications
drug DRUGBANK Tropicamide
disease MESH Infectious Diseases
disease IDO quality
pathway REACTOME Reproduction
disease MESH severe acute respiratory syndrome
disease IDO history
disease MESH Comorbidity
drug DRUGBANK L-Valine

Original Article

(Visited 9 times, 1 visits today)